Dynamics of immunosuppression in hamsters with experimental visceral leishmaniasis
Carregando...
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRAS DIVULG CIENTIFICA
Autores
Citação
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, v.44, n.7, p.666-670, 2011
Resumo
Immunosuppression has been reported to occur during active visceral leishmaniasis and some factors such as the cytokine profile may be involved in this process. In the mouse model of cutaneous leishmaniasis using Leishmania (Leishmania) major, the Th1 response is related to protection while the Th2 response is related to disease progression. However, in hamsters, which are considered to be an excellent model for the study of visceral leishmaniasis, this dichotomy is not observed. Using outbred 45- to 60-day-old (140 to 150 g) male hamsters infected intraperitoneally with 2 x 10(7) L. (L.) chagasi amastigotes, we evaluated the immune response of spleen cells and the production of cytokines. We used 3 to 7 hamsters per group evaluated. We detected a preserved response to concanavalin A measured by index of proliferation during all periods of infection studied, while a proliferative response to Leishmania antigen was detected only at 48 and 72 h post-infection. Messenger RNA from cytokines type 1 (IL-2, TNF-alpha, IFN-gamma) and type 2 (IL-4, IL-10 and TGF-beta) detected by reverse transcriptase polymerase chain reaction and produced by spleen cells showed no qualitative difference between control non-infected hamsters and infected hamsters during any period of infection evaluated. Cytokines were measured by the DNA band intensity on agarose gel using the Image Lab 1D L340 software with no differences observed. In conclusion, the present results showed an antigen-dependent immunosuppression in hamsters with active visceral leishmaniasis that was not related to the cytokine profile.
Palavras-chave
Immunosuppression, Leishmania (Leishmania) chagasi, Hamster, Cytokine, T-cell proliferation
Referências
- Goto H, 2004, BRAZ J MED BIOL RES, V37, P615, DOI 10.1590/S0100-879X2004000400020
- REINER NE, 1987, J IMMUNOL, V138, P1926
- Streit JA, 2001, J IMMUNOL, V166, P1921
- Rodrigues OR, 2009, IMMUNOBIOLOGY, V214, P101, DOI 10.1016/j.imbio.2008.07.001
- Melby PC, 2001, J IMMUNOL, V166, P1912
- SQUIRES KE, 1989, J IMMUNOL, V143, P4244
- BARBOSA AA, 1987, BRAZ J MED BIOL RES, V20, P63
- BASAK SK, 1992, EUR J IMMUNOL, V22, P2041, DOI 10.1002/eji.1830220813
- BUNNMORENO MM, 1985, CLIN EXP IMMUNOL, V59, P427
- CARVALHO EM, 1981, INFECT IMMUN, V33, P498
- Dasgupta S, 1999, PARASITOL RES, V85, P594, DOI 10.1007/s004360050600
- DWYER DM, 1976, J IMMUNOL, V117, P2081
- GIFAWESEN C, 1989, INFECT IMMUN, V57, P3091
- HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59
- Melby PC, 1998, INFECT IMMUN, V66, P2135
- Mookerjee A, 2003, INFECT IMMUN, V71, P2439, DOI 10.1128/IAI.71.5.2439-2446.2003
- NICKOL AD, 1985, PARASITE IMMUNOL, V7, P439, DOI 10.1111/j.1365-3024.1985.tb00089.x
- RODRIGUES V, 1992, PARASITE IMMUNOL, V14, P49, DOI 10.1111/j.1365-3024.1992.tb00005.x
- Rodrigues V, 1998, INFECT IMMUN, V66, P1233
- Vasconcellos RCS, 1996, BRAZ J MED BIOL RES, V29, P615